Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

Entospletinib effectively prevents eye and skin GVHD in mice.

Alpha 6 + /MHCI - cells have stem cell traits and are similar to mouse hair follicle stem cells.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

Obesity worsens skin health and losing weight can improve skin conditions.

Nanotechnology therapies can help improve quality of life for those with hair loss.

The mesenchymal stem cell-conditioned medium gel improved burn healing and hair growth in rats better than other treatments.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Non-immune factors play a significant role in alopecia areata.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

10% hPL is best for growing mesenchymal stem cells, while 10% FBS is best for hepatocytes.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Similar treatments might work for different types of scarring hair loss.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

The HATMSC1 cell line from fat tissue can produce helpful factors for regenerative and immune therapies.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Alopecia areata is caused by the immune system attacking hair follicles.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.